GO:0090181 regulation of cholesterol metabolic process: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090181 describes any process that modulates the rate, frequency, or extent of cholesterol metabolism, the chemical reactions and pathways involving cholesterol, the principal sterol of vertebrates.
• Cholesterol homeostasis is maintained by coordinated regulation of synthesis, uptake, efflux, and conversion to bile acids and steroid hormones.
• Key regulatory nodes include SREBP2, HMGCR, LDLR, ABCA1, ABCG1, CYP7A1, and nuclear receptors such as LXR and FXR.
• Dysregulation of cholesterol metabolic process is linked to atherosclerosis, nonalcoholic fatty liver disease, osteoarthritis, and cancer.
• Thyroid hormone, insulin, and oxysterol signaling intersect with cholesterol metabolic regulation, making it a central metabolic hub.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of regulatory genes in cholesterol metabolism.
Description
GO:0090181, regulation of cholesterol metabolic process, is a biological process ontology term that encompasses any process modulating the rate, frequency, or extent of cholesterol metabolism. Cholesterol is the principal sterol of vertebrates and serves as a precursor for bile acids, steroid hormones, and vitamin D, making its metabolic regulation essential for membrane integrity, lipid trafficking, and systemic energy balance. The term captures both positive and negative regulatory inputs that tune cholesterol synthesis, uptake, esterification, efflux, and catabolism in response to nutritional, hormonal, and inflammatory cues. Researchers study GO:0090181 to understand how cells maintain cholesterol homeostasis and how its disruption contributes to metabolic, cardiovascular, and neurodegenerative diseases. Because cholesterol metabolic regulation intersects with glucose and lipid metabolism, it is a focal point for therapeutic target discovery and biomarker development.
regulation of cholesterol metabolic process At A Glance
| GO ID | GO:0090181 |
|---|---|
| GO term | regulation of cholesterol metabolic process |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the rate, frequency, or extent of cholesterol metabolism, including synthesis, uptake, efflux, and conversion to bile acids and steroid hormones |
| Key regulators | SREBP2, HMGCR, LDLR, ABCA1, ABCG1, CYP7A1, LXR, FXR |
| Associated diseases | Atherosclerosis, nonalcoholic fatty liver disease, osteoarthritis, cancer |
| Research methods | CRISPR knockout/knock-in, RNA-seq, proteomics, lipidomics, ChIP-seq |
What Is GO:0090181?
GO:0090181 regulation of cholesterol metabolic process is defined as any process that modulates the rate, frequency, or extent of cholesterol metabolism, the chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. In practice, this term includes signaling events, transcriptional control, and post-translational mechanisms that adjust cholesterol synthesis, transport, storage, and conversion.
Why Is regulation of cholesterol metabolic process Important in Cell Biology?
Regulation of cholesterol metabolic process is critical because cholesterol is indispensable for membrane structure, lipid raft signaling, and synthesis of bile acids and steroid hormones, yet its excess drives atherosclerosis and metabolic disease. Understanding GO:0090181 helps explain how cells integrate hormonal, nutritional, and inflammatory signals to maintain cholesterol balance, and how failures in this regulation contribute to human pathology.
• Maintains membrane fluidity and lipid raft integrity through controlled cholesterol synthesis and uptake.
• Prevents cholesterol accumulation that leads to atherosclerosis and cardiovascular disease.
• Supports bile acid synthesis and enterohepatic circulation via CYP7A1 regulation.
• Links thyroid hormone and insulin signaling to systemic lipid homeostasis.
• Modulates macrophage function and inflammatory responses in innate immunity.
• Contributes to osteoarthritis pathogenesis through the CH25H-CYP7B1-RORα axis.
• Provides targets for lipid-lowering therapies such as statins and PCSK9 inhibitors.
• Serves as a model for studying feedback regulation of biosynthetic pathways.
• Influences cancer cell proliferation by supplying cholesterol for membrane biogenesis.
• Enables CRISPR screening to identify novel regulators of cholesterol metabolism.
What Happens During regulation of cholesterol metabolic process?
SREBP2-mediated transcriptional control of cholesterol synthesis
In simple terms: When cells need more cholesterol, a sensor protein called SREBP2 turns on the genes that make it.
SREBP2 is a master transcription factor that activates genes encoding HMGCR, HMGCS1, LDLR, and other enzymes of the mevalonate pathway when sterol levels are low. This feedback loop ensures that cholesterol synthesis and uptake match cellular demand, and its dysregulation is linked to hypercholesterolemia.
HMGCR and the mevalonate pathway
In simple terms: HMGCR is the rate-limiting enzyme that commits cells to making cholesterol.
HMGCR catalyzes the conversion of HMG-CoA to mevalonate, the committed step in cholesterol biosynthesis. Its activity is regulated transcriptionally by SREBP2 and post-translationally by sterol-induced degradation, making it a key node in GO:0090181.
LDLR-mediated cholesterol uptake
In simple terms: LDLR pulls cholesterol-carrying particles from the blood into cells.
The LDL receptor (LDLR) binds circulating LDL and mediates its endocytosis, delivering cholesterol to the cell. LDLR expression is controlled by SREBP2 and by PCSK9-mediated degradation, and mutations in LDLR cause familial hypercholesterolemia.
ABCA1/ABCG1-mediated cholesterol efflux
In simple terms: ABCA1 and ABCG1 pump excess cholesterol out of cells onto HDL particles.
ABCA1 and ABCG1 are ATP-binding cassette transporters that promote efflux of cholesterol and phospholipids to lipid-poor apolipoproteins, forming HDL. This process is regulated by LXR and is critical for reverse cholesterol transport and macrophage foam cell prevention.
Bile acid synthesis and FXR feedback
In simple terms: The liver converts cholesterol into bile acids, and FXR signals back to limit further conversion.
CYP7A1 catalyzes the rate-limiting step in bile acid synthesis from cholesterol. Bile acids activate FXR, which suppresses CYP7A1 transcription via SHP, creating a negative feedback loop that regulates cholesterol catabolism.
Oxysterol and nuclear receptor signaling
In simple terms: Oxidized cholesterol derivatives act as signals to control cholesterol metabolism.
Oxysterols such as 25-hydroxycholesterol are generated by CH25H and activate LXR and RORα, influencing cholesterol efflux, inflammation, and osteoarthritis progression. This axis exemplifies how cholesterol metabolites feed back on GO:0090181.
Key Genes Involved in GO:0090181 regulation of cholesterol metabolic process
The following genes and proteins are central to the regulation of cholesterol metabolic process (GO:0090181).
| Gene | Major Role | Research Relevance |
|---|---|---|
| SREBP2 | Master transcription factor activating cholesterol synthesis genes | Target for studying feedback regulation and hypercholesterolemia |
| HMGCR | Rate-limiting enzyme of mevalonate pathway | Statin target; key node in cholesterol biosynthesis |
| LDLR | Mediates LDL uptake from circulation | Mutations cause familial hypercholesterolemia |
| PCSK9 | Promotes LDLR degradation | Therapeutic target for lipid lowering |
| ABCA1 | Cholesterol efflux transporter to ApoA-I | Defects cause Tangier disease; HDL biogenesis |
| ABCG1 | Cholesterol efflux to HDL | Macrophage foam cell formation |
| CYP7A1 | Rate-limiting enzyme in bile acid synthesis | Regulated by FXR; cholesterol catabolism |
| CYP27A1 | Sterol 27-hydroxylase in bile acid synthesis | Alternative pathway of bile acid synthesis |
| LXRA | Nuclear receptor activated by oxysterols | Induces ABCA1/ABCG1 and cholesterol efflux |
| LXRB | Nuclear receptor regulating cholesterol efflux | Overlaps with LXRA in reverse cholesterol transport |
| FXR | Bile acid-activated nuclear receptor | Suppresses CYP7A1 via SHP; feedback regulation |
| SHP | Orphan nuclear receptor mediating FXR effects | Represses CYP7A1 transcription |
| CH25H | Enzyme producing 25-hydroxycholesterol | Regulates RORα and osteoarthritis |
| CYP7B1 | Oxysterol 7α-hydroxylase | Part of CH25H-CYP7B1-RORα axis |
| RORα | Nuclear receptor activated by oxysterols | Regulates cholesterol metabolism and inflammation |
| INSIG1 | Retains SREBP in ER | Controls SREBP processing and cholesterol synthesis |
| SCAP | SREBP cleavage-activating protein | Senses sterols and escorts SREBP |
| NPC1L1 | Intestinal cholesterol absorption | Target of ezetimibe |
How Is regulation of cholesterol metabolic process Regulated?
Regulation of cholesterol metabolic process is controlled by a network of transcription factors, nuclear receptors, and post-translational mechanisms. SREBP2 and its negative regulator INSIG1 sense ER sterol levels and adjust transcription of biosynthetic genes. LXR and FXR respond to oxysterols and bile acids, respectively, to control efflux and catabolism. Thyroid hormone and insulin signaling also modulate cholesterol synthesis and clearance, linking systemic metabolic status to GO:0090181. Additionally, PCSK9 regulates LDLR protein levels, and CH25H-derived oxysterols activate RORα to influence cholesterol metabolism in tissues such as cartilage.
regulation of cholesterol metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LDLR | Familial hypercholesterolemia | Knockout mouse or HepG2 KO cells |
| ABCA1 | Tangier disease, HDL deficiency | Macrophage-specific KO or knock-in |
| CYP7A1 | Bile acid malabsorption, NAFLD | Liver-specific KO or overexpression |
| CH25H | Osteoarthritis | Chondrocyte-specific KO or point mutation |
| SREBP2 | Metabolic syndrome, cancer | Inducible overexpression or KO |
Atherosclerosis and cardiovascular disease
Impaired regulation of cholesterol metabolic process leads to accumulation of LDL cholesterol in arterial walls, promoting foam cell formation and atherosclerosis. Defects in ABCA1 or LDLR cause familial hypercholesterolemia and Tangier disease, highlighting the clinical importance of GO:0090181.
Nonalcoholic fatty liver disease and metabolic syndrome
Dysregulated cholesterol synthesis and bile acid metabolism contribute to hepatic steatosis and nonalcoholic steatohepatitis. FXR and CYP7A1 dysfunction disrupt bile acid homeostasis, exacerbating liver injury.
Osteoarthritis
The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis pathogenesis, linking oxysterol signaling to cartilage degradation.
Cancer
Cancer cells often reprogram cholesterol metabolism to support proliferation and membrane biogenesis, making GO:0090181 regulators potential therapeutic targets.
From regulation of cholesterol metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HMGCR affect cholesterol synthesis? | HMGCR knockout cell line |
| Does a point mutation in LDLR impair LDL uptake? | LDLR point-mutation knock-in |
| Can ABCA1 overexpression increase cholesterol efflux? | ABCA1 overexpression cell model |
| Does CYP7A1 knockout alter bile acid pool? | CYP7A1 knockout mouse |
| Does CH25H knockout affect osteoarthritis? | CH25H knockout chondrocytes |
| Can SREBP2 be tagged for localization studies? | SREBP2 tagged knock-in |
How to Study the regulation of cholesterol metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Identify essential regulators of cholesterol synthesis |
| RNA-seq | Transcriptional changes | Map SREBP2/LXR target genes |
| ChIP-seq | Transcription factor binding | Locate SREBP2 and LXR binding sites |
| Lipidomics | Cholesterol and oxysterol levels | Quantify metabolic changes |
| Isotope tracing | Flux through mevalonate pathway | Measure cholesterol synthesis rate |
| Proteomics | Protein abundance and modifications | Study HMGCR degradation |
| CRISPR library screening | Phenotypic hits | Discover novel cholesterol regulators |
| High-content imaging | Cellular cholesterol distribution | Visualize efflux and uptake |
CRISPR knockout and knock-in models
CRISPR-Cas9 knockout of genes such as HMGCR, LDLR, or ABCA1 enables loss-of-function studies to determine their role in cholesterol metabolic regulation. Knock-in of point mutations can model familial hypercholesterolemia variants.
Transcriptomics and ChIP-seq
RNA-seq and ChIP-seq can identify SREBP2 and LXR target genes and map their regulatory networks in cholesterol metabolism.
Lipidomics and flux analysis
Mass spectrometry-based lipidomics quantifies cholesterol and oxysterol species, while isotope tracing measures flux through the mevalonate and bile acid pathways.
Proteomics and interactomics
Proteomic approaches can identify post-translational modifications and protein-protein interactions regulating HMGCR stability and SREBP processing.
How CRISPR Can Be Used to Study GO:0090181 regulation of cholesterol metabolic process
Knockout
CRISPR knockout of genes such as HMGCR, LDLR, ABCA1, or CYP7A1 provides definitive loss-of-function models to test their causal role in regulation of cholesterol metabolic process.
Point Mutation
Point mutations can be introduced into LDLR or ABCA1 to mimic patient variants and study their impact on cholesterol uptake or efflux.
Knock-in
Knock-in of tagged SREBP2 or HMGCR allows live-cell imaging and proteomic analysis of their regulation.
Overexpression
Overexpression of ABCA1 or CYP7A1 can enhance cholesterol efflux or bile acid synthesis, providing gain-of-function models for GO:0090181.
How EDITGENE Supports regulation of cholesterol metabolic process Research
Researchers studying regulation of cholesterol metabolic process-related genes often need to determine whether a candidate gene is causally involved in cholesterol homeostasis or is merely a bystander. EDITGENE provides CRISPR-based cell models and screening services to accelerate this functional validation.
Contact EDITGENE today to design your custom CRISPR model for regulation of cholesterol metabolic process research.
Frequently Asked Questions About regulation of cholesterol metabolic process
What is GO:0090181 regulation of cholesterol metabolic process?
GO:0090181 is a biological process term describing any process that modulates the rate, frequency, or extent of cholesterol metabolism, including synthesis, uptake, efflux, and conversion to bile acids and steroid hormones.
What genes are involved in regulation of cholesterol metabolic process?
Key genes include SREBP2, HMGCR, LDLR, PCSK9, ABCA1, ABCG1, CYP7A1, LXRA, LXRB, FXR, CH25H, CYP7B1, and RORα.
How is cholesterol metabolism regulated?
Cholesterol metabolism is regulated by SREBP2 feedback, LXR/FXR nuclear receptor signaling, oxysterol sensors, and post-translational control of HMGCR and LDLR.
What diseases are linked to dysregulation of cholesterol metabolic process?
Atherosclerosis, familial hypercholesterolemia, nonalcoholic fatty liver disease, osteoarthritis, and cancer are linked to dysregulation of cholesterol metabolism.
What is the role of SREBP2 in cholesterol metabolism?
SREBP2 is a transcription factor that activates genes of the mevalonate pathway and LDLR when sterol levels are low.
How does FXR regulate bile acid synthesis?
FXR is activated by bile acids and suppresses CYP7A1 transcription via SHP, providing negative feedback on cholesterol catabolism.
What is the CH25H-CYP7B1-RORα axis?
It is an oxysterol signaling pathway where CH25H produces 25-hydroxycholesterol, CYP7B1 metabolizes it, and RORα mediates downstream effects in osteoarthritis.
How can CRISPR be used to study cholesterol metabolism?
CRISPR knockout, knock-in, and overexpression models allow causal testing of genes involved in cholesterol synthesis, efflux, and bile acid production.
What methods measure cholesterol metabolic flux?
Isotope tracing, lipidomics, and RNA-seq are commonly used to measure cholesterol synthesis, oxysterol levels, and transcriptional changes.
Why is regulation of cholesterol metabolic process important for drug discovery?
It provides targets such as HMGCR, PCSK9, and LXR for lipid-lowering and metabolic therapies.
Conclusion
GO:0090181 regulation of cholesterol metabolic process is a central biological process that integrates transcriptional, post-translational, and nuclear receptor signaling to maintain cholesterol homeostasis. Its dysregulation underlies major human diseases including atherosclerosis, fatty liver disease, and osteoarthritis, making it a high-value area for functional genomics and therapeutic development. CRISPR-based models and multi-omics approaches continue to reveal new regulatory nodes within this process.
References
- 1. Mullur R et al.. 2014. Thyroid hormone regulation of metabolism.. Physiol Rev 94(2):355-82 PMID: 24692351
- 2. Chen L et al.. 2019. Regulation of glucose and lipid metabolism in health and disease.. Sci China Life Sci 62(11):1420-1458 PMID: 31686320
- 3. Yan J et al.. 2020. Lipid Metabolism in Regulation of Macrophage Functions.. Trends Cell Biol 30(12):979-989 PMID: 33036870
- 4. Schade DS et al.. 2020. Cholesterol Review: A Metabolically Important Molecule.. Endocr Pract 26(12):1514-1523 PMID: 33471744
- 5. Chiang JY. 2013. Bile acid metabolism and signaling.. Compr Physiol 3(3):1191-212 PMID: 23897684
- 6. Parente M et al.. 2023. Regulation of cholesterol metabolism: New players for an old physiological process.. J Cell Biochem 124(10):1449-1465 PMID: 37796135
- 7. Choi WS et al.. 2019. The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis.. Nature 566(7743):254-258 PMID: 30728500
- 8. Goedeke L et al.. 2012. Regulation of cholesterol homeostasis.. Cell Mol Life Sci 69(6):915-30 PMID: 22009455
